Reduced cholesterol is associated with the depressive-like behavior in rats through modulation of the brain 5-HT1A receptor

Lipids in Health and Disease

Volumn 14, Issue 1, 2015, Pages

  Sun, Shuqin ^a   Yang, Shuo ^a   Mao, Yongjun ^a   Jia, Xiujuan ^a   Zhang, Zheng ^a  

^a QINGDAO UNIVERSITY   (China)

Author keywords

Cholesterol; Chronic stress; Depression; Medial prefrontal cortex; Serotonin

Indexed keywords

BRAIN RECEPTOR; CHOLESTEROL; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR; N-(2-(4-(2-METHOXYPHENYL)-1-PIPERAZINYL)ETHYL)-N-(2-PYRIDINYL)CYCLOHEXANECARBOXAMIDE; PIPERAZINE DERIVATIVE; PYRIDINE DERIVATIVE; SEROTONIN 1 ANTAGONIST;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BRAIN LEVEL; CHOLESTEROL BLOOD LEVEL; CHRONIC STRESS; CONTROLLED STUDY; DEPRESSION; DIET SUPPLEMENTATION; FOOD INTAKE; FORCED SWIM TEST; GAS CHROMATOGRAPHY; HIPPOCAMPUS; IMMOBILITY; LOCOMOTION; MALE; MASS SPECTROMETER; NEUROMODULATION; NONHUMAN; OPEN FIELD TEST; PREFRONTAL CORTEX; RAT; SEROTONINERGIC SYSTEM; SUCROSE PREFERENCE TEST; ANIMAL; CHEMISTRY; COMPLICATION; DISEASE MODEL; MASS FRAGMENTOGRAPHY; MENTAL STRESS; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

RATTUS;

ANIMALS; CHOLESTEROL; DEPRESSION; DISEASE MODELS, ANIMAL; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HIPPOCAMPUS; MALE; PIPERAZINES; PREFRONTAL CORTEX; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN 5-HT1 RECEPTOR ANTAGONISTS; STRESS, PSYCHOLOGICAL;

EID: 84925809860     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/s12944-015-0020-7     Document Type: Article

References (59)

1. Balci B. The modification of serum lipids after acute coronary syndrome and importance in clinical practice. Curr Cardiol Rev. 2011;7:272-6.
2. de Jonge P, Rosmalen JG, Kema IP, Doornbos B, van Melle JP, Pouwer F, et al. Psychophysiological biomarkers explaining the association between depression and prognosis in coronary artery patients: a critical review of the literature. Neurosci Biobehav Rev. 2010;35:84-90.
3. Stapelberg NJ, Neumann DL, Shum DH, McConnell H, Hamilton-Craig I. A topographical map of the causal network of mechanisms underlying the relationship between major depressive disorder and coronary heart disease. Aust N Z J Psychiatry. 2011;45:351-69.
4. Maes M, Smith R, Christophe A, Cosyns P, Desnyder R, Meltzer H. Fatty acid composition in major depression: decreased omega 3 fractions in cholesteryl esters and increased C20: 4 omega 6/C20:5 omega 3 ratio in cholesteryl esters and phospholipids. J Affect Disord. 1996;38:35-46.
5. Maes M, Christophe A, Delanghe J, Altamura C, Neels H, Meltzer HY. Lowered omega3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatry Res. 1999;85:275-91.
6. Fava M, Abraham M, Pava J, Shuster J, Rosenbaum J. Cardiovascular risk factors in depression. The role of anxiety and anger. Psychosomatics. 1996;37:31-7.
7. Partonen T, Haukka J, Virtamo J, Taylor PR, Lonnqvist J. Association of low serum total cholesterol with major depression and suicide. Br J Psychiatry. 1999;175:259-62.
8. Engelberg H. Low serum cholesterol and suicide. Lancet. 1992;339:727-9.
9. Rabe-Jablonska J, Poprawska I. Levels of serum total cholesterol and LDL-cholesterol in patients with major depression in acute period and remission. Med Sci Monit. 2000;6:539-47.
10. Boston PF, Dursun SM, Reveley MA. Cholesterol and mental disorder. Br J Psychiatry. 1996;169:682-9.
11. Kaplan JR, Muldoon MF, Manuck SB, Mann JJ. Assessing the observed relationship between low cholesterol and violence-related mortality. Implications for suicide risk. Ann N Y Acad Sci. 1997;836:57-80.
12. Hensler JG. Differential regulation of 5-HT1A receptor-G protein interactions in brain following chronic antidepressant administration. Neuropsychopharmacology. 2002;26:565-73.
13. Middlemiss DN, Price GW, Watson JM. Serotonergic targets in depression. Curr Opin Pharmacol. 2002;2:18-22.
14. Diaz-Mataix L, Scorza MC, Bortolozzi A, Toth M, Celada P, Artigas F. Involvement of 5-HT1A receptors in prefrontal cortex in the modulation of dopaminergic activity: role in atypical antipsychotic action. J Neurosci. 2005;25:10831-43.
15. Bantick RA, De Vries MH, Grasby PM. The effect of a 5-HT1A receptor agonist on striatal dopamine release. Synapse. 2005;57:67-75.
16. Celada P, Bortolozzi A, Artigas F. Serotonin 5-HT1A receptors as targets for agents to treat psychiatric disorders: rationale and current status of research. CNS Drugs. 2013;27:703-16.
17. Paila YD, Murty MR, Vairamani M, Chattopadhyay A. Signaling by the human serotonin(1A) receptor is impaired in cellular model of Smith-Lemli-Opitz Syndrome. Biochim Biophys Acta. 2008;1778:1508-16.
18. Shrivastava S, Pucadyil TJ, Paila YD, Ganguly S, Chattopadhyay A. Chronic cholesterol depletion using statin impairs the function and dynamics of human serotonin(1A) receptors. Biochemistry. 2010;49:5426-35.
19. Drevets WC, Price JL, Furey ML. Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Struct Funct. 2008;213:93-118.
20. MacQueen GM, Yucel K, Taylor VH, Macdonald K, Joffe R. Posterior hippocampal volumes are associated with remission rates in patients with major depressive disorder. Biol Psychiatry. 2008;64:880-3.
21. Miguel-Hidalgo JJ, Rajkowska G. Morphological brain changes in depression: can antidepressants reverse them? CNS Drugs. 2002;16:361-72.
22. Hamani C, Nobrega JN. Preclinical studies modeling deep brain stimulation for depression. Biol Psychiatry. 2012;72:916-23.
23. Meltzer HY, Massey BW, Horiguchi M. Serotonin receptors as targets for drugs useful to treat psychosis and cognitive impairment in schizophrenia. Curr Pharm Biotechnol. 2012;13:1572-86.
24. Donaldson ZR, Nautiyal KM, Ahmari SE, Hen R. Genetic approaches for understanding the role of serotonin receptors in mood and behavior. Curr Opin Neurobiol. 2013;23:399-406.
25. Beckett S, Marsden CA. The effect of central and systemic injection of the 5-HT1A receptor agonist 8-OHDPAT and the 5-HT1A receptor antagonist WAY100635 on periaqueductal grey-induced defence behaviour. J Psychopharmacol. 1997;11:35-40.
26. Aguiar DC, Terzian AL, Guimaraes FS, Moreira FA. Anxiolytic-like effects induced by blockade of transient receptor potential vanilloid type 1 (TRPV1) channels in the medial prefrontal cortex of rats. Psychopharmacology (Berl). 2009;205:217-25.
27. Paxinos G, Watson CR, Emson PC. AChE-stained horizontal sections of the rat brain in stereotaxic coordinates. J Neurosci Methods. 1980;3:129-49.
28. Zhu WL, Shi HS, Wang SJ, Xu CM, Jiang WG, Wang X, et al. Increased Cdk5/p35 activity in the dentate gyrus mediates depressive-like behaviour in rats. Int J Neuropsychopharmacol. 2012;15:795-809.
29. Willner P, Towell A, Sampson D, Sophokleous S, Muscat R. Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology (Berl). 1987;93:358-64.
30. Porsolt RD, Anton G, Blavet N, Jalfre M. Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol. 1978;47:379-91.
31. Lin YH, Liu AH, Xu Y, Tie L, Yu HM, Li XJ. Effect of chronic unpredictable mild stress on brain-pancreas relative protein in rat brain and pancreas. Behav Brain Res. 2005;165:63-71.
32. Jansen PJ, Lutjohann D, Abildayeva K, Vanmierlo T, Plosch T, Plat J, et al. Dietary plant sterols accumulate in the brain. Biochim Biophys Acta. 2006;1761:445-53.
33. Lutjohann D, Brzezinka A, Barth E, Abramowski D, Staufenbiel M, von Bergmann K, et al. Profile of cholesterol-related sterols in aged amyloid precursor protein transgenic mouse brain. J Lipid Res. 2002;43:1078-85.
34. Lu L, Hope BT, Dempsey J, Liu SY, Bossert JM, Shaham Y. Central amygdala ERK signaling pathway is critical to incubation of cocaine craving. Nat Neurosci. 2005;8:212-9.
35. Srinivasan MP, Kamath PK, Manjrekar PA, Unnikrishnan B, Ullal A, Kotekar MF, et al. Correlation of severity of coronary artery disease with insulin resistance. N Am J Med Sci. 2013;5:611-4.
36. Byrkjeland R, Edvardsen E, Njerve IU, Arnesen H, Seljeflot I, Solheim S. Insulin levels and HOMA index are associated with exercise capacity in patients with type 2 diabetes and coronary artery disease. Diabetol Metab Syndr. 2014;6:36.
37. McGuire AW, Eastwood JA, Hays RD, Macabasco-O'Connell A, Doering LV. Depressed or not depressed: untangling symptoms of depression in patients hospitalized with coronary heart disease. Am J Crit Care. 2014;23:106-16.
38. Rudisch B, Nemeroff CB. Epidemiology of comorbid coronary artery disease and depression. Biol Psychiatry. 2003;54:227-40.
39. Welch CA, Czerwinski D, Ghimire B, Bertsimas D. Depression and costs of health care. Psychosomatics. 2009;50:392-401.
40. Rutledge T, Vaccarino V, Johnson BD, Bittner V, Olson MB, Linke SE, et al. Depression and cardiovascular health care costs among women with suspected myocardial ischemia: prospective results from the WISE (Women's Ischemia Syndrome Evaluation) Study. J Am Coll Cardiol. 2009;53:176-83.
41. Ramamurthy G, Trejo E, Faraone SV. Depression treatment in patients with coronary artery disease: a systematic review. Prim Care Companion CNS Disord. 2013;15 Suppl 5:doi:10.4088/PCC.13r01509
42. Kim JM, Stewart R, Kang HJ, Jeong BO, Kim SY, Bae KY, et al. Longitudinal associations between serum cholesterol levels and suicidal ideation in an older Korean population. J Affect Disord. 2014;152-154:517-21.
43. Papakostas GI, Ongur D, Iosifescu DV, Mischoulon D, Fava M. Cholesterol in mood and anxiety disorders: review of the literature and new hypotheses. Eur Neuropsychopharmacol. 2004;14:135-42.
44. Zhu WL, Wang SJ, Liu MM, Shi HS, Zhang RX, Liu JF, et al. Glycine site N-methyl-D-aspartate receptor antagonist 7-CTKA produces rapid antidepressant-like effects in male rats. J Psychiatry Neurosci. 2013;38:306-16.
45. Simons K, Ikonen E. How cells handle cholesterol. Science. 2000;290:1721-6.
46. Mouritsen OG, Zuckermann MJ. What's so special about cholesterol? Lipids. 2004;39:1101-13.
47. Duan Y, Fu W, Wang S, Ni Y, Zhao R. Cholesterol deregulation induced by chronic corticosterone (CORT) stress in pectoralis major of broiler chickens. Comp Biochem Physiol A Mol Integr Physiol. 2014;176C:59-64.
48. Galman C, Angelin B, Rudling M. Prolonged stimulation of the adrenals by corticotropin suppresses hepatic low-density lipoprotein and high-density lipoprotein receptors and increases plasma cholesterol. Endocrinology. 2002;143:1809-16.
49. Bilici M, Efe H, Koroglu MA, Uydu HA, Bekaroglu M, Deger O. Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments. J Affect Disord. 2001;64:43-51.
50. Maes M, De Vos N, Pioli R, Demedts P, Wauters A, Neels H, et al. Lower serum vitamin E concentrations in major depression. Another marker of lowered antioxidant defenses in that illness. J Affect Disord. 2000;58:241-6.
51. Maes M, Smith R, Christophe A, Vandoolaeghe E, Van Gastel A, Neels H, et al. Lower serum high-density lipoprotein cholesterol (HDL-C) in major depression and in depressed men with serious suicidal attempts: relationship with immune-inflammatory markers. Acta Psychiatr Scand. 1997;95:212-21.
52. Wu H, Lu D, Jiang H, Xiong Y, Qu C, Li B, et al. Simvastatin-mediated upregulation of VEGF and BDNF, activation of the PI3K/Akt pathway, and increase of neurogenesis are associated with therapeutic improvement after traumatic brain injury. J Neurotrauma. 2008;25:130-9.
53. Zheng Z, Chen B. Effects of Pravastatin on neuroprotection and neurogenesis after cerebral ischemia in rats. Neurosci Bull. 2007;23:189-97.
54. Guirland C, Zheng JQ. Membrane lipid rafts and their role in axon guidance. Adv Exp Med Biol. 2007;621:144-55.
55. Klempin F, Beis D, Mosienko V, Kempermann G, Bader M, Alenina N. Serotonin is required for exercise-induced adult hippocampal neurogenesis. J Neurosci. 2013;33:8270-5.
56. Szewczyk B, Kotarska K, Daigle M, Misztak P, Sowa-Kucma M, Rafalo A, et al. Stress-induced alterations in 5-HT1A receptor transcriptional modulators NUDR and Freud-1. Int J Neuropsychopharmacol. 2014;17:1763-75.
57. Bravo JA, Dinan TG, Cryan JF. Early-life stress induces persistent alterations in 5-HT1A receptor and serotonin transporter mRNA expression in the adult rat brain. Front Mol Neurosci. 2014;7:24.
58. Saxena R, Chattopadhyay A. Membrane cholesterol stabilizes the human serotonin(1A) receptor. Biochim Biophys Acta. 1818;2012:2936-42.
59. Sengupta D, Chattopadhyay A. Identification of cholesterol binding sites in the serotonin1A receptor. J Phys Chem B. 2012;116:12991-6.